This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody & ADC Summit At ChinaBio
Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026

Dr. Zhenhua Ren, PhD
Research Professor at Changping Laboratory
Speaker

Profile

Zhenhua Ren, Ph.D, is a research professor at Changping Laboratory. Dr. Ren earned his doctoral degree from the Institute of Biophysics at the Chinese Academy of Sciences and completed his postdoctoral research at the University of Texas Southwestern Medical Center in the United States. With over a decade of experience in tumor immunology, Dr. Ren is dedicated to advancing cancer immunotherapy. His research focuses on cytokine engineering, antibody engineering, antibody-cytokine fusion proteins, and the development of novel immunotherapeutic strategies targeting the tumor microenvironment. His innovations have significantly reduced cytokine toxicity and side effects, while enhancing therapeutic effectiveness against tumors and providing essential guidance for the clinical application of cytokines.

Agenda Sessions

  • New Strategies for Targeted Cancer Immunotherapy

    14:30